Advertisement

Drugs & Therapy Perspectives

, Volume 35, Issue 1, pp 48–48 | Cite as

Correction to: Ginkgo biloba extract EGb 761® in the symptomatic treatment of mild-to-moderate dementia: a profile of its use

  • Kate McKeage
  • Katherine A. Lyseng-WilliamsonEmail author
Correction
  • 191 Downloads

Correction to: Drugs & Therapy Perspectives (2018) 34(8):358–366  https://doi.org/10.1007/s40267-018-0537-8

The article Ginkgo biloba extract EGb 761® in the symptomatic treatment of mild-to-moderate dementia: a profile of its use, written by Kate McKeage and Katherine A. Lyseng-Williamson, was originally published Online First without open access. After publication in volume 34, issue 8, pages 358–366, Ipsen Pharma requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Ipsen Pharma . The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The original article has been corrected.

Copyright information

© Springer Nature 2018

Authors and Affiliations

  1. 1.SpringerAucklandNew Zealand

Personalised recommendations